- Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
- Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
- Cibus Announces $13.0 Million Registered Direct Offering
- Cibus to Participate in Upcoming June Investor Events
- Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
- Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
- Cibus to Participate in the BMO Global Farm to Market Conference
- Cibus Reports First Quarter Financial Results and Provides Business Update
- Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
- Cibus Reports Fourth Quarter Financial Results and Provides Business Update
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.71 |
---|---|
High | 8.71 |
Low | 8.16 |
Bid | 7.86 |
Offer | 9.32 |
Previous close | 8.68 |
Average volume | 387.96k |
---|---|
Shares outstanding | 25.46m |
Free float | 16.21m |
P/E (TTM) | -- |
Market cap | 213.83m USD |
EPS (TTM) | -18.29 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼